QA: Mylan INC in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000069499_2013_Mylan_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000069499, Mylan INC

  xvar xval
0 AssetsCurrent 3,902,717,000
1 IntangibleAssetsNetIncludingGoodwill 5,740,112,000
2 PropertyPlantAndEquipmentNet 1,397,216,000
3 remainder_Assets 891,852,000
4 LiabilitiesCurrent 2,193,503,000
5 LiabilitiesNoncurrent 6,108,307,000
6 remainder_Liabilities 274,259,000
7 CostOfGoodsAndServicesSold 3,887,806,000
8 SellingGeneralAndAdministrativeExpense 1,400,747,000
9 ResearchAndDevelopmentExpense 401,341,000
10 remainder_Expenses 466,711,000
11 remainder_Revenues 6,796,110,000
12 remainder_NetIncome 3,429,000
13 remainder_ComprehensiveNetIncome -743,000
  yvar yval
0 Assets 11,931,897,000
1 Liabilities 8,576,069,000
2 Expenses 6,156,605,000
3 Revenues 6,796,110,000
4 StockholdersEquity 3,355,828,000
5 NetIncome 642,934,000
6 ComprehensiveNetIncome 642,562,500
7 BaseVar 16,732,426,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.776
9 EconomicCapitalRatio 2.12

Edgar->Model Mapping

Feature Distribution

Change over Time